• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hum Immunol . Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients

tetano

Editor, Senior Moderator
Hum Immunol


. 2021 Nov 4;S0198-8859(21)00252-4.
doi: 10.1016/j.humimm.2021.10.007. Online ahead of print.
Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients


Haitao Xiang[SUP] 1 [/SUP], Yingze Zhao[SUP] 2 [/SUP], Xinyang Li[SUP] 1 [/SUP], Peipei Liu[SUP] 2 [/SUP], Longlong Wang[SUP] 1 [/SUP], Meiniang Wang[SUP] 3 [/SUP], Lei Tian[SUP] 3 [/SUP], Hai-Xi Sun[SUP] 3 [/SUP], Wei Zhang[SUP] 4 [/SUP], Ziqian Xu[SUP] 2 [/SUP], Beiwei Ye[SUP] 2 [/SUP], Xiaoju Yuan[SUP] 2 [/SUP], Pengyan Wang[SUP] 5 [/SUP], Ning Zhang[SUP] 6 [/SUP], Yuhuan Gong[SUP] 6 [/SUP], Chengrong Bian[SUP] 7 [/SUP], Zhaohai Wang[SUP] 7 [/SUP], Linxiang Yu[SUP] 7 [/SUP], Jin Yan[SUP] 7 [/SUP], Fanping Meng[SUP] 7 [/SUP], Changqing Bai[SUP] 7 [/SUP], Xiaoshan Wang[SUP] 3 [/SUP], Xiaopan Liu[SUP] 1 [/SUP], Kai Gao[SUP] 8 [/SUP], Liang Wu[SUP] 3 [/SUP], Longqi Liu[SUP] 3 [/SUP], Ying Gu[SUP] 9 [/SUP], Yuhai Bi[SUP] 6 [/SUP], Yi Shi[SUP] 6 [/SUP], Shaogeng Zhang[SUP] 7 [/SUP], Chen Zhu[SUP] 7 [/SUP], Xun Xu[SUP] 9 [/SUP], Guizhen Wu[SUP] 2 [/SUP], George F Gao[SUP] 10 [/SUP], Naibo Yang[SUP] 11 [/SUP], William J Liu[SUP] 12 [/SUP], Penghui Yang[SUP] 13 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the pandemic of coronavirus disease 2019 (COVID-19). Great international efforts have been put into the development of prophylactic vaccines and neutralizing antibodies. However, the knowledge about the B cell immune response induced by the SARS-CoV-2 virus is still limited. Here, we report a comprehensive characterization of the dynamics of immunoglobin heavy chain (IGH) repertoire in COVID-19 patients. By using next-generation sequencing technology, we examined the temporal changes in the landscape of the patient's immunological status and found dramatic changes in the IGH within the patient's immune system after the onset of COVID-19 symptoms. Although different patients have distinct immune responses to SARS-CoV-2 infection, by employing clonotype overlap, lineage expansion, and clonotype network analyses, we observed a higher clonotype overlap and substantial lineage expansion of B cell clones 2-3 weeks after the onset of illness, which is of great importance to B-cell immune responses. Meanwhile, for preferences of V gene usage during SARS-CoV-2 infection, IGHV3-74 and IGHV4-34, and IGHV4-39 in COVID-19 patients were more abundant than those of healthy controls. Overall, we present an immunological resource for SARS-CoV-2 that could promote both therapeutic development as well as mechanistic research.

Keywords: B-cell receptor repertoire; COVID-19; Clonal expansion; SARS-CoV-2.
 
Back
Top Bottom